Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

Clinical trial NCT03028350 · COMPLETED

Trial details

NCT number: NCT03028350
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma, Aspirin-Induced

Start date: 2017-07-17
Primary completion: 2023-04-25
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.